amsacrine has been researched along with Leukemia, Myelomonocytic, Acute in 8 studies
Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.
Leukemia, Myelomonocytic, Acute: A pediatric acute myeloid leukemia involving both myeloid and monocytoid precursors. At least 20% of non-erythroid cells are of monocytic origin.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Forty-eight patients with acute myelogenous leukemia (AML) not eligible for anthracycline or mitoxantrone treatment, mostly due to cardiac contraindications, were given aggressive therapy using m-amsacrine (AMSA) in combination with conventional or high-dose cytarabine for remission induction." | 5.07 | AMSA combination chemotherapy in patients with acute myelogenous leukemia unsuitable for standard antileukemic treatment. ( Heit, W; Maschmeyer, G; Willborn, K, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (75.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fouillard, L | 1 |
| Labopin, M | 1 |
| Meloni, G | 1 |
| Polge, E | 1 |
| Gorin, NC | 1 |
| Frassoni, F | 1 |
| Fukushima, T | 1 |
| Kuriyama, K | 1 |
| Yoshida, S | 1 |
| Nagai, K | 1 |
| Miyazaki, Y | 1 |
| Moriuti, Y | 1 |
| Tomonaga, M | 1 |
| Ong, ST | 1 |
| Kueh, YK | 1 |
| Wahlin, A | 1 |
| Brinch, L | 1 |
| Hörnsten, P | 1 |
| Evensen, SA | 1 |
| Oberg, G | 1 |
| Simonsson, B | 1 |
| Hedenus, M | 1 |
| Nørgaard, JM | 1 |
| Olesen, LH | 1 |
| Olesen, G | 1 |
| Meyer, K | 1 |
| Kristensen, JS | 1 |
| Bendix, K | 1 |
| Pedersen, B | 1 |
| Kjeldsen, E | 1 |
| Hokland, P | 1 |
| Maschmeyer, G | 1 |
| Willborn, K | 1 |
| Heit, W | 1 |
| Jehn, U | 2 |
| Zittoun, R | 1 |
| Suciu, S | 1 |
| Fiere, D | 1 |
| Haanen, C | 1 |
| Peetermans, M | 1 |
| Löwenberg, B | 1 |
| Willemze, R | 1 |
| Solbu, G | 1 |
| Stryckmans, P | 1 |
| Heinemann, V | 1 |
4 trials available for amsacrine and Leukemia, Myelomonocytic, Acute
4 other studies available for amsacrine and Leukemia, Myelomonocytic, Acute
| Article | Year |
|---|---|
Comparison of BAVC to BuCy regimens in autologous stem cell transplantation for adult patients with acute myeloid leukemia.
Topics: Adolescent; Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carmus | 2004 |
[Allogeneic bone marrow transplantation for two patients with acute myeloid leukemia with trilineage myelodysplasia (T-MDS)].
Topics: Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combi | 1994 |
Hepatic candidiasis: persistent pyrexia in a patient with acute myeloid leukaemia after recovery from consolidation therapy-induced neutropenia.
Topics: Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Candidiasis; Cytosine; Eto | 1993 |
FAB M4 and high CD14 surface expression is associated with high cellular resistance to Ara-C and daunorubicin: implications for clinical outcome in acute myeloid leukaemia.
Topics: Aclarubicin; Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Amsacrine; Antigens, Neoplas | 2001 |